Full year revenue and EBITDA in line with guidance Accelerating product development post-COVID-19 to become a leading global clinical diagnostic company in infectious diseases Paris, France and Eastleigh, UK 27 April 2023...

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases Paris, France and Eastleigh, UK –...

Paris, France and Camberley, UK – 6 January 2023 – Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it was notified by Biosynex...

Paris, France and Eastleigh, UK – 7 Dec 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that Edwin Snape has informed the Board...

Paris, France and Camberley, UK – 10 November 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that David Allmond is stepping down as...